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Some patients with active tuberculosis lack a delayed skin test reaction to PPD 
(1-4). The basis for this immunologic hyporesponsiveness has been investigated 
using in vitro systems. Tuberculin-induced blastogenic responses of lymphocytes 
are decreased in such patients compared with healthy tuberculin reactors (5, 6). 
This is not simply due to a dearth of responsive cells in the circulation.  Rather, 
monocytes act  as  antigen-specific  suppressor  cells  in  patients  with  pulmonary 
tuberculosis  (5)  and  tuberculous  pleurisy  (8).  FcTR  +  lymphocytes,  i.e.,  cells 
bearing receptors for the Fc portion of IgG, also suppress PPD-induced blasto- 
genesis in tuberculous patients (9). 
T  cell proliferation  is critically dependent on the lymphokine,  IL-2 (10,  1 1). 
This hormone  is a  prerequisite  for clonal expansion  of antigen-specific T  cells 
(12) and activation of the effector limb of cell-mediated immune responses (13, 
14). IL-2-dependent cytotoxicity may be important for containment of facultative 
intracellular parasites such as Mycobacterium  leprae (15) and Mycobacterium  tuber- 
culosis. 
We  investigated  IL-2  homeostasis  in  patients  with  active,  newly  diagnosed 
pulmonary tuberculosis.  Depressed PPD-induced blastogenesis in these patients 
was associated  with  abnormalities  in  IL-2  production  and  IL-2-R  generation 
restricted to the response to tuberculin PPD. In 10 of 22 patients, IL-2 generation 
was depressed and unaffected by adherent cell depletion; these patients showed 
more extensive disease by radiographic criteria. Dysregulation of production and 
response to the pivotal cytokine IL-2 thus may be critical factors in the defective 
cellular immune response in tuberculosis. 
Materials and Methods 
Study Population.  22  patients  with  newly  diagnosed active  pulmonary  tuberculosis 
hospitalized  at  University  Hospitals  at  Cleveland,  Cleveland  Veterans  Administration 
Hospital,  and  Cleveland  Metropolitan General  Hospital,  Cleveland,  OH were studied. 
Patients with  factors potentially affecting the immune response were excluded: (a) age 
over 65 yr, (b) antituberculosis  therapy for over 14 d, (c) concomitant debilitating  diseases. 
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Diagnosis was based on the demonstration of acid fast bacilli in sputum or biopsy specimens 
and was eventually confirmed by positive culture for M. tuberculosis. The chest roentgen- 
ogram  obtained  from  each  patient  at  the  time  of study  was  graded  for  extent  of 
tuberculosis according to National Tuberculosis and Respiratory Association criteria (16). 
A  group of 14  healthy  tuberculin  reactors,  age- and  sex-matched to the patients,  was 
studied concurrently with the patients. 
Preparation  of Cells.  50 ml of heparinized blood (20 U/ml) was obtained from each 
subject. Peripheral blood mononuclear cells (PBMC) 1 were separated by FicolI-Hypaque 
(Pharmacia Fine Chemicals, Piscataway, N  J) sedimentation (I 7). The fraction of monocytes 
in PBMC was determined by peroxidase cytochemistry (18). Adherent cells were prepared 
by suspending PBMC (5 x  108/ml) in RPMI-1640 (M. A. Bioproducts, Walkersville, MD) 
supplemented with 10% vol/vol heat inactivated FCS (Hyclone Laboratories, Logan, UT) 
and incubating 5-10 ml of the cell suspension in plastic petri dishes (100 x  20 mm; Falcon 
Labware,  Oxnard,  CA) at  37°C  for  1  h.  After  nonadherent  cells were  removed the 
adherent monolayers were dislodged by gentle scraping with a  rubber policeman. The 
resultant adherent cell population consisted of 85-90% monocytes (peroxidase staining) 
and was 99% viable by trypan blue exclusion. Nonadherent cells were washed onto 600 
mg acid-treated nylon wool columns and incubated at 37°C for 30 min. The cells then 
eluted were T  cell-enriched (>85% SRBC rosetting) and monocyte-depleted (<1% per- 
oxidase positive in both patients and healthy donors). 
Antigens  and  Reagents.  PPD was a  gift of Lederle Laboratories (Div.  American Cy- 
anamid Co., Wayne, N  J) and used at a final concentration of 100 #g/ml. Streptolysin 0 
was purchased from Fisher Scientific Co., Pittsburgh, PA and used at a  1:50 dilution. We 
found these concentrations to be optimal for stimulating both lymphocyte blastogenesis 
and IL-2 generation in a group of healthy donors.  Indomethacin (Sigma Chemical Co., 
St. Louis, MO) was dissolved in 95% ethyl alcohol at 10 mg/ml, diluted at RPMI-1640, 
and used at a final concentration of 1 #g/ml. 
Generation oflL-2-containing Supernatants.  PBMC or T  cells were incubated in 24-well 
Linbro plates (Flow Laboratories, Inc., McLean, VA) at 3 X  106/ml/well in RPMI-1640 
supplemented with L-glutamine (2 mM), penicillin (50 U/ml), gentamicin (50 #g/ml), and 
2%  vol/vol  heat-inactivated  pooled  human  serum.  Cell  cultures  were  stimulated  by 
antigens (PPD or streptolysin 0).  After 48 h, supernatants were separated from cells by 
centrifugation at 500 g for 10 min and stored at -20°C until assay. 
IL-2 Assay.  The IL-2-dependent cytotoxic murine T  cell line CTLL-20 was used for 
assay purposes. This cell line has been kept in culture with IL-2 containing supernatants 
of con A-activated rat splenocytes for over 2 yr, and was a gift of Dr. J. Finke (Cleveland 
Clinic  Foundation,  Cleveland, OH) (19).  CTLL-20 cells were washed extensively, and 
suspended in DME (4.5  gm/liter glucose) (M.  A. Bioproducts) at  105/ml.  100 #i of the 
cell suspension was placed in flat-bottomed microtiter wells (3072; Falcon Labware) along 
with 100 ~! of supernatants. IL-2 determinations were performed in triplicate. The total 
duration of culture was 24 h;  1 #Ci of [SH]thymidine sp act 6.7 Ci/mmole (ICN Labora- 
tories Inc., Irving, CA) was added per well for the last 5 h  of culture.  Cells were then 
harvested with a  Mash II harvester (M.  A. Bioproducts) and SH activity was assayed by 
liquid scintillation spectrometry. 
IL-2 activity was expressed as [3H]thymidine incorporation of CTLL-20 in culture with 
1:2 dilutions of supernatants of antigen-stimulated cell cultures. Study of serial dilutions 
of supernatants of antigen-stimulated cells revealed that maximal [3H]thymidine incor- 
poration of the indicator cells occurred at the 1:2 dilution, which was consistently in the 
linear portion of the dose-response curve; unlike supernatants of mitogen stimulated cells, 
prozone inhibition was not apparent (20). 
Assessment  of IL-2-R  Generation.  The  mAb,  anti-Tac  (21,  22),  a  gift  from  Dr.  T. 
Waldmann (Bethesda,  MD),  was used for assessment of IL-2-R. PBMC in  RPMI-1640 
(106/ml) were stimulated with PPD for 5 d, then incubated with 50 t~l of a  1:100 dilution 
of anti-Tac antibody for 30 min at 4 ° C. Washed cells were further incubated with FITC- 
i Abbreviations used in this paper:  LP, low producer of IL-2; NP, normal producer of IL-2. 1 164  DEFECTIVE INTERLEUKIN  2  PRODUCTION  IN  TUBERCULOSIS 
TABLE  I 
Antigen-induced IL-2 Production and Blastogenesis in PBMC from Tuberculosis Patients and 
Healthy Donors 
Antigen 
IL-2 activity (cpm + SEM)*  Blastogenesis (cpm __. SEM; [SH]TdR) 
TB patients  Healthy donors  TB patients  Healthy donors 
(n = 22)  (n = 14)  (n = 22)  (n = 14) 
PPD  3,571 + 790  17,947  ± 4,406  6,655 ± 1,410  18,187  ± 2,132 
Streptolysin 0  53,493 ± 16,636  55,781  + 17,409  36,561  + 15,813  37,592 + 15,344 
* [SH]Thymidine incorporation of CTLL-20 after incubation with a 1:2 dilution of supernatants of 
antigen-stimulated PBMC. 
conjugated  goat  anti-mouse  IgG  (Cappel  Laboratories,  Cochranville,  PA)  at  a  1:20 
dilution. Fluorescence of washed cells was then analyzed with a FACS EPICS V. 
Assay of[SH]Thymidine  Incorporation.  Cells were cultured at 7.5 X 105/ml in RPMI- 
1640 supplemented with 20% vol/voi heat-inactivated pooled human serum.  100 #1 of 
cell suspension was incubated in round bottomed microtiter plate wells (Falcon Labware). 
PPD and streptolysin 0 were added to quadruplicate wells. In some experiments, purified 
IL-2 (Electro-Nucleonics Inc., Silver Springs, MD) was added to wells. This preparation 
of IL-2 has comparable activity (640 half-maximal U/ml) to the National Institutes of 
Health IL-2 standard and was used at final concentrations of 1-10%. When assayed with 
CTLL-20, a 10% vol/vol concentration of this preparation consistently produced maximal 
responses, whereas a 1% vol/vol concentration showed IL-2 activity uniformly exceeding 
50% of maximum. Cultures were incubated at 37°C in 5% CO~ for 5 d. 18 h before the 
termination of culture, 1.0 #Ci of [SH]thymidine, sp act 6.7 Ci/mmol (ICN Laboratories, 
Inc.), was added per well. Cultures were then harvested and [SH]TdR assessed  by liquid 
scintillation spectrometry. 
Statistical Analysis.  Group  means  were  compared using the  Student's  t  test  unless 
otherwise indicated. 
Results 
IL-2 Activity in Supernatants  of Antigen-stimulated  PBMC.  Supernatants were 
prepared from antigen-activated PBMC of patients with active tuberculosis and 
a  group  of healthy  tuberculin  positive  individuals.  The  IL-2  activity  of such 
supernatants  is shown in  Table I.  Mean  PPD-induced  IL-2 activity was  81.2% 
lower  in  patients  with  active  disease  as  compared  with  healthy  donors  (p  < 
0.001).  In contrast, streptolysin 0-induced IL-2 activity was similar in superna- 
tants  of PBMC  from  both  groups.  Table  I  also  shows  antigen-induced  [SH]- 
thymidine incorporation in PBMC for patients and controls. Again, mean PPD- 
induced  blastogenesis  was  significantly  lower  in  patients  (p  <  0.001),  while 
streptolysin 0-induced blastogenesis was comparable to controls. Thus, patients 
with active tuberculosis showed a  concomitant defect in both IL-2 production 
and blastogenesis by PBMC, which was restricted to the disease-related antigen, 
PPD. 
The observation of low IL-2 activity in supernatants of PPD-activated PBMC 
in tuberculosis could reflect a factor in these supernatants interfering with IL-2- 
mediated proliferation of the assay cells.  To exclude this possibility,  CTLL-20 
cells were cocultured with PBMC supernatants plus serial dilutions (1:2-1:32) of 
the rat IL-2 (supernatants of Con A-stimulated rat splenocytes) used to maintain TOOSSI  ET  AL.  1165 
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FIGURE  1.  IL-2 activity in supernatants  of PPD-stimulated T  cell cultures for tuberculosis 
patients (left) and controls (right). Dashed line indicates mean IL-2 activity of controls -  2 SD. 
This line can be used to segregate tuberculosis patients into NP (above line) and LP (below 
line). 
this cell line.  Supernatants of PPD-stimulated PBMC from four patients with 
tuberculosis had no effect on IL-2-mediated proliferation of CTLL-20 (data not 
shown). 
Role  of Adherent  Cells in  Regulation  of IL-2 Production  in  Tuberculosis.  To 
examine the role of adherent cells in PPD-induced IL-2 production in tubercu- 
losis,  PBMC were depleted of such cells by two sequential procedures: plastic 
adherence  and  nylon-wool  column  incubation  as  outlined  in  Materials  and 
Methods. T-enriched cells thus obtained were comparable in monocyte content 
(< 1% peroxidase positive) in both the patient group and the controls. Superna- 
tants of PPD-stimulated T  cells showed significantly more IL-2 activity as com- 
pared with PBMC supernatants for both the patients (19,186 +  4,736 vs. 3,571 
+  790) (p <  0.01) and the healthy subjects (54,604 ±  6,714 vs. 17,946 +  4,406) 
(p < 0.00 I). IL-2 activity in supernatants from PPD-stimulated T cells of patients, 
however, remained significantly lower than that of healthy donors (p <  0.001). 
Fig.  1 is a  scattergram of IL-2 activities in supernatants of PPD-stimulated T 
cells for both patients (left) and controls (right). The dashed line indicates mean 
PPD-induced  IL-2  activity  of T  cell  supernatants  from  controls  minus  two 
standard deviations. This line was used to separate the tuberculosis patients into 
two categories. In 12 patients, PPD-stimulated T  cell production of IL-2 could 
not be distinguished from healthy donors; this group showed a significant increase 
in  IL-2  activity on adherent cell removal, from 4,572  +  1,314,  to  32,973  + 
6,350, (p <  0.001) mimicking the pattern observed in PPD-reactive individuals. 
They were designated normal producers of IL-2 (NP). The effect of adherent 
cell depletion on blastogenic responses was also examined. In these experiments 
T  cells were reconstituted with 5% adherent cells to assure adequate accessory 
activity. Adherent cell depletion resulted in increased PPD-induced blastogenesis 
in NP patients from 9,789  ±  2,681  in PBMC to  15,563  ±  3,370 in cultures of 
T  cell plus 5% adherent cells (p <  0.01). 1166  DEFECTIVE  INTERLEUKIN 2  PRODUCTION  IN  TUBERCULOSIS 
TABLE II 
Clinical Features of Patient Groups 
Subject  Age  Male/female 
(yr)  ratio 
Initial PPD 
Chest x-ray  (5 TU)  Percent 
Moder-  PBMC per- 
Far ad-  ately  Mini- Mili-  Posi-  Nega- oxidase-posi- 
vanced  ad-  mal  arT  tive  tive  tive 
vanced 
NP tuberculosis  50.5 
patients (n = 
12) 
LP tuberculosis  48.7 
patients (n = 
10) 
12:0 
8:2 
2*  9  0  1  7/8'  1/8  25.6 +__ 6.4* 
8*  1  0  1  2]4  2/4*  27.6 + 5.1' 
* Differ by Fisher's exact scientific  test, p = 0.027. 
* Not significantly  different. 
The second group of tuberculosis patients was composed of 10 individuals in 
whom PPD-induced IL-2 activity was significantly depressed and remained low 
despite  adherent  cell  removal:  2,075  4-  579  PBMC  vs.  2,642  4-  502  T  cell 
cultures; they were designated low producers (LP). Adherent cell depletion also 
augmented PPD-induced  blastogenesis  slightly in  these  patients (2,720  +  880 
PBMC vs. 7,570 _+ 2,534 T  cells +  5% adherent cells) but this failed to achieve 
statistical significance (p >  0.05). 
Clinical features of the two categories of tuberculosis  patients are  shown in 
Table  II.  The  major difference between  the two groups  was  the significantly 
higher number  of LP patients with far advanced disease on chest x-ray (p  = 
0.027).  Each group contained one patient with miliary tuberculosis and neither 
included patients with minimal lesions. No difference was observed between the 
two  groups  in  the  fraction  of PBMC  identified as  monocytes by  peroxidase 
staining.  Data  on  PPD  skin test reactivity did not show significant differences 
between the two categories. 
Comparison of Adherent Suppressor Cell Activity in Patients with Tuberculosis and 
Controls.  Depletion studies indicated that adherent suppressor cells contributed 
to low PPD-induced IL-2 production by PBMC in our NP tuberculosis patients. 
In  order  to  quantify the  suppressive  capacity of adherent cells,  T  cells  were 
cocultured with graded numbers of adherent cells (2 and 25%  of T  cells) and 
PPD-induced IL-2 activity determined.  Results are shown in Fig.  2.  Adherent 
cells from NP patients were more suppressive of IL-2 production than was the 
case in  healthy donors;  the presence  of as few as 2%  adherent cells in  T  cell 
cultures caused a  50% drop in IL-2 activity, from 32,973  4- 6,350 to  15,267  + 
5,216  (p  <  0.05).  In  PPD-reactive  healthy controls,  on the  other  hand,  IL-2 
activity of supernatants of antigen-stimulated T  cells and T  cells +  2% adherent 
cells was comparable (59,079 4- 7,415 vs. 40,722 4- 6,498) (p >  0.05); a significant 
5.3-fold suppression of IL-2 activity was apparent, however, when 25% adherent 
cells were present in T  cell cultures (p <  0.001). Indomethacin (1/~g/ml) present 
in cultures  of T  cells with  25%  adherent cells did not significantly block sup- TOOSSI  ET  AL.  1167 
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FIGURE 2.  PPD-induced IL-2 activity in cultures of PBMC, T cells (T), T cells + 2% adherent 
cell (ADH), T cells + 25% adherent cell, and T cells + 25% adherent cells in the presence of 
1 #g/ml indomethacin. Each bar represents mean + SEM. 
TABLE  III 
Effect of Purified IL-2 (1% vol/vol) on PPD-induced Blastogenesis of 
PBMC in Tuberculosis Patients and Healthy Donors 
Experiment  IL-2  PPD  Blastogenesis* 
Patients (n =  12)  -  -  1.3 ±  0.3 
-  +  5.8  ±  1.7 
+  -  4.2±  1.1 
+  +  10.5 ±  1.9 
Controls (n =  10)  -  -  1.5 ± 0.3 
-  +  25.9 ± 3.2 
+  -  7.9 ±  1.8 
+  +  36.1  ±  5.6 
* [SH]TdR in  PBMC cultures.  Data are  shown as  mean  cpm 
(x I0-~). 
±  SEM 
pression  of PPD-induced  IL-2  activity  in  tuberculosis  NP  (4,873  +  2,523  vs. 
7,945  +  4,662)  (p >  0.05)  while in the  healthy donors,  there  was a  partial but 
significant reversal of suppression by indomethacin  (10,972  +  3,398 vs. 27,775 
+  7,465) (p <  0.05). 
Response  of Mononuclear Cells from  Tuberculous  Patients to Purified IL-2.  We 
studied the effect of purified IL-2 on PBMC responsiveness to PPD in 12 patients 
with tuberculosis.  Purified IL-2 (Lot No.  1608-54;  Electro-Nucleonics Inc.) was 
cocuhured with PBMC at  1% vol/vol concentration  in proliferation assays. This 
concentration  of purified  IL-2  contains  20  U/ml  of activity as determined  by 
modified Probit analysis in relation to an IL-2 standard that exceeds the activity 
in supernatants  of tuberculin-stimulated  adherent-depleted  T  cells from tuber- 
culin reactors (mean 17.25 U/ml, n  =  5). Results are shown in Table III. There 
was an apparent  increase  in  [3H]TdR  of PPD-stimulated  PBMC  of patients  in 
the  presence of IL-2. This could be accounted  for,  however,  by the  increased 1 168  DEFECTIVE  INTERLEUKIN 2  PRODUCTION IN  TUBERCULOSIS 
TABLE IV 
Expression of lL-2-R (Tac Antigen) on PPD-stimulated PBMC  from 
Tuberculosis Patients and Healthy Donors 
Exp. 
Percent of PBMC reactive with anti-Tac 
TB patient  Healthy donor 
1  4.36*  23.36 
2  3.47  33.25 
3  3.94  39.20 
4  9.69  -- 
Mean :t: SD  5.36:1: 2.9*  31.93:1: 8* 
* PBMC were cultured with PPD for 5 d. Anti-Tac-reactive cells were 
assessed  by indirect immunofluorescence  and FACS  analysis. 
*p< 0.01. 
[3H]thymidine incorporation of PBMC cultured in the presence of IL-2 without 
PPD.  Similar  results  were obtained  with  higher  concentration  of IL-2,  5  and 
10% vol/vol, although the greater mitogenic activity of IL-2 alone complicated 
interpretation of these data. Virtually identical results were observed in healthy 
PPD-reactive  controls.  These  data  indicate  that  exogenous  IL-2  was  directly 
mitogenic  for  PBMC  but  unable  to  reverse  hyporesponsiveness  to  PPD  in 
tuberculosis. 
T  Cell Expression of IL-2-R in Patients with Tuberculosis.  The above findings 
indicate not only a  defect in PPD-induced IL-2 production in tuberculosis, but 
also an inability of exogenous IL-2 to correct tuberculin hyporesponsiveness of 
mononuclear cells. The latter could be secondary to lack of development of IL- 
2-R on PPD-activated PBMC. Accordingly, we evaluated the expression of the 
IL-2-R in four patients and three tuberculin reactive controls by FACS analysis 
using the  mAb anti-Tac.  Table  IV shows these results.  The  fraction  of PPD- 
stimulated  PBMC  that  reacted  with  anti-Tac  was  significantly  depressed  in 
tuberculous subjects (p <  0.01). Three of the four patients studied were NPs of 
IL-2, as defined above, and one was an LP. Streptolysin 0-induced Tac expres- 
sion, however, was similar in two patients as compared with their controls (data 
not shown). Therefore, the depression in Tac expression, as well as the defects 
in IL-2 production and blastogenesis, were restricted to responses to tuberculin. 
Discussion 
These  studies  show  that  patients  with  newly  diagnosed,  active  pulmonary 
tuberculosis have a  defect in  PPD-stimulated  IL-2 production and  lymphocyte 
blastogenesis. Responses to streptococcal antigen, however, were comparable to 
those of healthy donors. Deficient IL-2 production has been reported in a number 
of experimental  settings  (23-25).  In  humans,  depressed  IL-2  production  has 
been  shown  in  patients  with  the  acquired  immunodeficiency  syndrome  (26), 
lepromatous leprosy (27), and recurrent oral herpes simplex virus infection (28). 
In patients with lepromatous leprosy, both purified IL-2 and recombinant  IL-2 
reversed the  unresponsiveness  of PBMC to antigen  (27,  29).  Furthermore,  in 
Mycobacterium  bovis infected mice, IL-2 corrected defective T  cell proliferation TOOSSI ET AL.  1169 
(30).  In  our  study,  however,  purified  IL-2  in  activities  producing  maximal 
responses in CTLL-20 and exceeding those generated by PPD-stimulated T  cells 
from healthy tuberculin reactors failed to correct PPD-activated PBMC prolif- 
eration; in these concentrations, IL-2 was directly mitogenic for PBMC both in 
controls and patients. Recombinant IL-2 also has mitogenic activity (29, 31) and, 
in  a  recent  study,  failed  to  reconstitute  M.  leprae  responses  in  lepromatous 
patients (31). The inability of exogenous IL-2 to correct PPD-stimulated PBMC 
unresponsiveness in tuberculosis was associated with deficient antigen-stimulated 
expression of IL-2-R identified by anti-Tac monoclonal antibody. This resembles 
the recent observations in lepromatous leprosy (31).  Antigen-restricted defects 
in production of and response to IL-2 could reflect abnormal immunoregulation 
by adherent cells that have been shown to depress PPD-induced blastogenesis in 
tuberculosis  (5).  Adherent  cell  suppression,  in  fact,  contributed  to  low  PPD- 
induced IL-2 production and T cell blastogenesis in one subset of our tuberculosis 
patients (NP). Regulation of antigen-stimulated T  cell IL-2 production by adher- 
ent cells in NP patients differed from healthy tuberculin reactors, however, in 
its greater magnitude and lack of indomethacin reversibility. These observations 
are consonant with the data on regulation of blastogenesis in tuberculosis (5, 28, 
32).  Prostaglandin E~, although a  known inhibitor of IL-2 production in both 
mitogen (33, 34) and antigen-activated cell systems (35) of healthy donors, does 
not appear to be a  major mediator of suppression by adherent cells in tubercu- 
losis. 
In the LP patients, PPD-induced T  cell IL-2 production remained low despite 
adherent cell depletion. LP patients were clinically distinct from NP patients in 
significantly higher  frequency (80%)  of far  advanced  lesions on  chest  x rays, 
indicating more extensive disease. Thus, in tuberculosis as in leprosy (36), more 
extensive tissue involvement was associated with more profound defects in cell- 
mediated immunity. The depressed T  cell IL-2 production in LP patients could 
be due to active suppression mediated by nonadherent lymphocytes present in 
this population. We have previously shown the capacity of Fc3,R  + lymphocytes 
to function as tuberculin-specific suppressor cells in tuberculosis (10).  Alterna- 
tively, the small residual monocyte content of nylon-wool-purified T  cells (<1% 
peroxidase  positive) could  contribute  to  depressed  IL-2  production.  Further 
studies will be necessary to evaluate these possibilities. 
The disturbed regulation of IL-2 homeostasis in tuberculosis must be placed 
in the context of other observations on the cellular interactions and cytokine 
cascade required for a  ceil-mediated immune response. In comparable clinical 
populations,  suppression  of  PPD-induced  blastogenesis  could  be  ascribed  to 
adherent monocytes (5), which also showed initially decreased surface expression 
of HLA-DR determinants followed by a  burst in their synthesis during in vitro 
cultivation (37), and increased production of IL-1 (38). These alterations in key 
immunoregulatory properties of mononuclear phagocytes may contribute to the 
disturbances in IL-2 homeostasis in tuberculosis. The ultimate consequence of 
dysregulation of IL-2  metabolism on  IFN-'y production and activation  of the 
mononuclear phagocyte as an effector cell is the subject of current investigations. 1170  DEFECTIVE  INTERLEUKIN  2  PRODUCTION  IN  TUBERCULOSIS 
Summary 
Patients  with  newly  diagnosed,  pulmonary  tuberculosis  had  a  tuberculin- 
specific defect in IL-2 production. Mean PPD-induced IL-2 activity was 81.2% 
lower in  patients as compared  with healthy tuberculin  reactors.  PPD-induced 
expression  of T  cell  IL-2  receptors  was  5.9  times  less  in  peripheral  blood 
mononuclear cells of patients with tuberculosis as compared with healthy tuber- 
culin reactors.  Furthermore, purified IL-2 failed to correct PPD-induced blas- 
togenesis in patients. Suppression by adherent cells was operative in one group 
of patients; adherent cell depletion increased their T  cell production of IL-2 7.2- 
fold. A second group of patients with low IL-2 production did not have suppres- 
sor adherent cells and were  clinically distinct, with more  extensive disease on 
chest x ray. The basis for low IL-2 production in such individuals is unknown. 
Disordered regulation of IL-2 metabolism may be a key feature in the depressed 
cellular immune response of tuberculosis. 
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